Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Publication year
2017Source
Radiotherapy and Oncology, 122, 2, (2017), pp. 295-299ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Radiation Oncology
Pulmonary Diseases
Medical Imaging
Journal title
Radiotherapy and Oncology
Volume
vol. 122
Issue
iss. 2
Page start
p. 295
Page end
p. 299
Subject
Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Medical Imaging - Radboud University Medical Center; Radiation Oncology - Radboud University Medical CenterAbstract
Retrospective evaluation of 188 advanced stage non-small cell lung cancer patients treated with IMRT or VMAT revealed a limited increase of moderate to severe acute esophageal toxicity after VMAT. Acute pulmonary toxicity and severe late toxicity were low. Overall survival did not differ between the IMRT and VMAT groups.
This item appears in the following Collection(s)
- Academic publications [246515]
- Faculty of Medical Sciences [93308]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.